A urine test can detect the onset of colon cancer
Researchers of Howard Hughes Medical Institute (United States) have created a simple and non-invasive urine test that, tested in experimental models, changes its color when … Read more
Researchers link a gene signature to the poor prognosis in non-small cell lung cancer
A recent work published in the scientific journal Cell Death & Disease It describes how a gene signature is linked to the poor prognosis of … Read more
Pharmacists are behind campaigns of deaths of children with cancer: AMLO
The President Andrés Manuel López Obrador accused three pharmaceutical companies, what They received millionaire contracts for stock medicines in previous administrations, to be behind the … Read more
They investigate the relationship of vitamin D deficiency with a higher incidence in colon cancer
Researchers at CIBER Cancer (CIBERONC) have described in one article the action of calcitriol in the stem cells of the colon. The alteration of these … Read more
Atezolizumab in combination with chemotherapy is approved for extended stage microcytic lung cancer
The European Commission has approved and granted the marketing authorization of atezolizumab (marketed as tecentriq) in combination with chemotherapy (carboplatin and etoposide) for initial first-line … Read more
The risk of death after breast cancer, diabetes and coronary heart disease could be controlled with a low-fat diet
A low-fat diet reduces the risk of death after breast cancer, the progression of diabetes and the onset of coronary heart disease, as shown by … Read more
Blocking a protein could facilitate a new treatment for the lethal form of prostate cancer
Blocking a kinase known as CDK7 triggers a reaction that causes the death of prostate cancer cells that have spread and are resistant to standard … Read more
New studies improve overall survival in advanced breast cancer HR +, HER2
Abemaciclib is the first and only CDK4 and 6 inhibitor in combination with fulvestrant that achieves a statistically significant increase in overall survival in pre, … Read more
Durvalumab demonstrates survival benefit in microcytic lung cancer with extended disease
Imfimzi (durvalumab) has demonstrated a significant benefit in overall survival and in lasting response rates in small cell lung cancer with extended disease in previously … Read more
The diagnosis of lung cancer may be advanced four years
A new test that analyzes the immune system's response to cancer in its earliest stages has been shown to be able to detect lung cancer … Read more